FDA Drug Application (006317) for SULFONAMIDES DUPLEX by LILLY

Back to FDA Applications sponsored by LILLY

Application Number006317
Product Number007
FormSUSPENSION;ORAL
Dosage250MG/5ML;250MG/5ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSULFONAMIDES DUPLEX
Active IngredientSULFADIAZINE; SULFAMERAZINE

Active IngredientCount
List of drugs with Active Ingredient SULFADIAZINE11
List of drugs with Active Ingredient SULFAMERAZINE10


Back to FDA Applications sponsored by LILLY